Use of blood products in sepsis: An evidence-based review

Critical Care Medicine

Volumn 32, Issue 11 SUPPL., 2004, Pages

  Zimmerman, Janice L ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN; BLOOD CLOTTING FACTOR; ERYTHROPOIETIN; FOLIC ACID; FRESH FROZEN PLASMA; HEMOGLOBIN; IRON;

ANEMIA; BLEEDING; BLOOD; BLOOD CLOTTING DISORDER; BLOOD TRANSFUSION; CLINICAL TRIAL; CONSENSUS DEVELOPMENT; DRUG INDICATION; DRUG PREFERENCE; ERYTHROCYTE TRANSFUSION; EVIDENCE BASED MEDICINE; HUMAN; INTENSIVE CARE; MEDICAL LITERATURE; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUESTIONNAIRE; REVIEW; RISK ASSESSMENT; SEPSIS; SURGERY; SYSTEMATIC REVIEW; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; TISSUE PERFUSION; TREATMENT OUTCOME;

ANTITHROMBINS; BLOOD COMPONENT TRANSFUSION; CONSENSUS DEVELOPMENT CONFERENCES; ERYTHROCYTE TRANSFUSION; ERYTHROPOIETIN; EVIDENCE-BASED MEDICINE; HUMANS; PLASMA; PLATELET TRANSFUSION; PRACTICE GUIDELINES; SEPSIS;

EID: 8444227812     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000145906.63859.1A     Document Type: Review

References (63)

1. Vincent JL, Baron J-F, Reinhart K, et al: Anemia and blood transfusion in critically ill patients. JAMA 2002; 288:1499-1507
2. Corwin H, Parsonnet KC, Gettinger A: RBC transfusion in the ICU: Is there a reason? Chest 1995; 108:767-771
3. Corwin HL, Gettinger A, Pearl RG, et al: The CRIT study: Anemia and blood transfusion in the critically ill - Current clinical practice in the United States. Crit Care Med 2004; 32: 39-52
4. Rivers E, Nguyen B, Havsted S, et al: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345:1368-1377
5. von Ahsen N, Müller C, Serke S, et al: Important role of nondiagnostic blood loss and blunted erythropoietic response in anemia of medical intensive care patients. Crit Care Med 1999; 27:2630-2639
6. Faquin WC, Schneider TJ, Goldberg MA: Effect of inflammatory cytokines on hypoxia-induced erythropoietin production. Blood 1992; 79:1987-1994
7. Vamvakas EC, Blajchman MA: Deleterious clinical effects of transfusion-associated immunomodulation: Fact or fiction? Blood 2001; 97:1180-1195
8. Claridge JA, Sawyer RG, Schulman AM, et al: Blood transfusions correlate with infections in trauma patients in a dose-dependent manner. Am Surg 2002; 68:566-572
9. Chelemer SB, Prato S, Cox PM, et al: Association of bacterial infection and red blood cell transfusion after coronary artery bypass surgery. Ann Thorac Surg 2002; 73:138-142
10. Hill GE, Frawley WH, Griffith KE, et al: Allogeneic blood transfusion increases the risk of postoperative bacterial infection: A meta-analysis. J Trauma 2003; 54:908-914
11. Malone DL, Dunne J, Tracy JK, et al: Blood transfusion, independent of shock severity, is associated with worse outcome in trauma. J Trauma 2003; 54:898-807
12. Leal-Noval SR, Rincón-Ferrari MD, García-Curiel A, et al: Transfusion of blood components and postoperative infection in patients undergoing cardiac surgery. Chest 2001; 119:1461-1468
13. Taylor RW, Manganaro L, O'Brien J, et al: Impact of allogenic packed red cell transfusion on nosocomial infection rates in the critically ill patient. Crit Care Med 2002; 30: 2249-2254
14. Vamvaka EC, Carven JH: RBC transfusion and postoperative length of stay in the hospital or the intensive care unit among patients undergoing coronary artery bypass graft surgery: The effects of confounding factors. Transfusion 2000; 40:832-839
15. Hébert PC, Wells G, Blajchman MA, et al: A multicenter, randomized, controlled clinical trial of transfusion in critical care. N Engl JMed 1999; 340:409-417
16. Purdy FR, Tweeddale MG, Merrick PM: Association of mortality with age of blood transfused in septic ICU patients. Can J Anaesth 1997; 44:1256-1261
17. Gilbert EM, Haupt MT, Mandanas RY, et al: The effect of fluid loading, blood transfusion, and catecholamine infusion on oxygen delivery and consumption in patients with sepsis. Am Rev Resp Dis 1986; 134:873-878
18. Mink RB, Pollack MM: Effect of blood transfusion on oxygen consumption in pediatric septic shock. Crit Care Med 1990; 18: 1087-1091
19. Lucking SE, Williams TM, Chaten FC, et al: Dependence of oxygen consumption on oxygen delivery in children with hyperdynamic septic shock and low oxygen extraction. Crit Care Med 1990; 18:1316-1319
20. Conrad SA, Dietrich KA, Hebert CA, et al: Effect of red cell transfusion on oxygen consumption following fluid resuscitation in septic shock. Circ Shock 1990; 31:419-429
21. Steffes CP, Bender JS, Levinson MA: Blood transfusion and oxygen consumption in surgical sepsis. Crit Care Med 1991; 19: 512-517
22. Silverman HJ, Tuna P: Gastric tonometry in patients with sepsis, effects of dobutamine infusions and packed red blood cell transfusions. Chest 1992; 102:184-188
23. Marik PE, Sibbald WJ: Effect of stored-blood transfusion on oxygen delivery in patients with sepsis. JAMA 1993; 269:3024-3029
24. Lorente JA, Landin L, dePablo R, et al: Effects of blood transfusion on oxygen transport variables in severe sepsis. Crit Care Med 1993; 21:1312-1318
25. Fernandas CJ, Akamine N, DeMarco FVC, et al: Red blood cell transfusion does not increase oxygen consumption in critically ill septic patients. Crit Care 2001; 5:362-367
26. Weiskopf RB, Viele MK, Feiner J, et al: Human cardiovascular response to acute, severe isovolemic anemia. JAMA 1998; 279:217-221
27. Hébert PC, Yetisir E, Martin C, et al: Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases? Crit Care Med 2001; 29:227-234
28. Hébert PC, Blajchman MA, Cook DJ, et al: Do blood transfusions improve outcomes related to mechanical ventilation? Chest 2001; 119: 1850-1857
29. Neilipovitz D, Hébert PC: Blood transfusion and sepsis. In: The Sepsis Text. JL Vincent, J Carlet, SM Opal (Eds). Klurver Academic Publishers, 2002, vol 23, pp 401-410
30. Task Force of the American College of Critical Care Medicine, Society of Critical Care Medicine: Practice parameters for hemodynamic support of sepsis in adult patients in sepsis. Crit Care Med 1999; 639-660
31. Wu W-C, Rathore SS, Wang Y, et al: Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med 2001; 345:1230-1236
32. Carson JL, Duff A, Poses RM, et al: Effect of anaemia and cardiovascular disease on surgical mortality and morbidity. Lancet 1996; 348:1055-1060
33. Corwin HL, Gettinger A, Rodriguez RM, et al: Efficacy of recombinant human erythropoietin in the critically ill patient: A randomized double-blind, placebo-controlled trial. Crit Care Med 1999; 27:2346-2350
34. Corwin HL, Gettinger A, Pearl RG, et al: Efficacy of recombinant human erythropoietin in critically ill patients. JAMA 2002; 28: 2827-2835
35. Rogiers P, Zhang H, Leeman M, et al: Erythropoietin response is blunted in critically ill patients. Intensive Care Med 1997; 23: 159-162
36. Hobisch-Hagen P, Wiedermann F, Mayr A, et al: Blunted erythropoietic response to anemia in multiply traumatized patients. Crit Care Med 2001; 29:743-747
37. Krafte-Jacobs B, Levetown ML, Bray GL, et al: Erythropoietin response to critical illness. Crit Care Med 1994; 22:821-826
38. Elliott JM, Virankabutra T, Jones S, et al: Erythropoietin mimics the acute phase response in critical illness. Crit Care 2003; 7:R35-R40
39. Abel J, Spannbrucker N, Fandrey J, et al: Serum erythropoietin levels in patients with sepsis and septic shock. Eur J Haematol 1996; 57:359-363
40. Nakamura T, Ebihara I, Shimada N, et al: Changes in plasma erythropoietin and interleukin-6 concentrations in patients with septic shock after hemoperfusion with polymyxin B-immobilized fiber. Intensive Care Med 1998; 24:1272-1276
41. Krafte-Jacobs B, Bock GH: Circulating erythropoietin and interleukin-6 concentrations increase in critically ill children with sepsis and septic shock. Crit Care Med 1996; 24: 1455-1459
42. Gabriel A, Kozek S, Chiari A, et al: High-dose recombinant human erythropoietin stimulates reticulocyte production in patients with multiple organ dysfunction syndrome. J Trauma 1998; 44:361-367
43. van Iperen CE, Gaillard CAJM, Kraaijenhagen RJ, et al: Response of erythropoiesis and iron metabolism to recombinant erythropoietin in intensive care unit patients. Crit Care Med 2000; 28:2773-2778
44. Macdougall IC, Cooper AC: Erythropoietin resistance: The role of inflammation and proinflammatory cytokines. Nephrol Dial Transplant 2002; 17(Suppl 11):39-43
45. College of American Pathologists: Practice parameter for the use of fresh-frozen plasma, cryoprecipitate, and platelets. JAMA 1994; 271:777-781
46. Guidelines for red blood cell and plasma transfusion for adults and children. Can Med Assoc J 1999; 156:S1-S24
47. American Society of Anaesthesiologists Task Force on Blood Component Therapy: Practice guidelines for blood component therapy. Anesthesiology 1996; 84:732-747
48. Medical Directors Advisory Committee, National Blood Transfusion Council: Guideline for the use of fresh-frozen plasma. S Afr Med J 1998; 88:1344-1347
49. Mammen EF: Antithrombin III: Its physiologic importance and role in DIC. Semin Thromb Haemost 1998; 24:19-25
50. Souter PJ, Thomas S, Hubbard AR, et al: Antithrombin inhibits lipopolysaccharide-induced tissue factor and interleukin-6 production by mononuclear cells, human umbilical vein endothelial cells, and whole blood. Crit Care Med 2001; 29:134-139
51. Inthorn D, Hoffmann JN, Hartl WH, et al: Effect of antithrombin III supplementation on inflammatory response in patient with severe sepsis. Shock 1998; 10:90-96
52. Fourrier F, Chopin C, Goudemand J, et al: Septic shock, multiple organ failure, and disseminated intravascular coagulation: Compared patterns of antithrombin III, protein C, and protein S deficiencies. Chest 1992; 101: 816-823
53. Warren BL, Eid A, Singer P, et al: High-dose antithrombin III in severe sepsis: A randomized controlled trial. JAMA 2001; 286: 1869-1878
54. Eisele B, Lamy M, Thijs LG, et al: Antithrombin III in patients with severe sepsis: A randomized, placebo-controlled, double-blind multicenter trial plus a meta-analysis on all randomized, placebo-controlled, double-blind trials with antithrombin III in severe sepsis. Intensive Care Med 1998; 24:663-672
55. Fourrier F, Chopin C, Heart J-J, et al: Double-blind, placebo-controlled trial of antithrombin III concentrates in septic shock with disseminated intravascular coagulation. Chest 1993; 104:882-888
56. Inthorn D, Hoffmann JM, Hartl WH, et al: Antithrombin III supplementation in severe sepsis: beneficial effects on organ dysfunction. Shock 1997; 8:328-334
57. Baudo F, Caimi TM, deCataldo F, et al: Antithrombin III (AT III) replacement therapy in patients with sepsis and/or post surgical complications: A double-blind, randomized, multicenter trial. Intensive Care Med 1998; 24:336-342
58. Fourrier F, Jourdain M, Tournoys A: Clinical trial results with antithrombin III in sepsis. Crit Care Med 2000; 28:S38-S43
59. Strauss R, Wehler M, Mehler K, et al: Thrombocytopenia in patients in the medical intensive care unit: Bleeding prevalence, transfusion requirements, and outcome. Crit Care Med 2002; 30:1765-1771
60. Vanderschueren S, DeWeerdt A, Malbrain M, et al: Thrombocytopenia and prognosis in intensive care. Crit Care Med 2000; 28: 1871-1876
61. Akca S, Haji-Michael P, de Mendonca A, et al: Time course of platelet counts in critically ill patients. Crit Care Med 2002; 30: 753-756
62. Rebulla P: Trigger for platelet transfusion. Vox Sang 2000; 78:179-182
63. Roseff SD, Luban NLC, Manno CS: Guidelines for assessing appropriateness of pediatric transfusion. Transfusion 2002; 42: 1398-1413